RIPK1 and familial pancreatic carcinoma: In addition, another anti-diabetic drug, the Vanadium compound, triggered various cell death in pancreatic cancer by inhibiting the cell cycle, increasing ROS, and upregulating RIPK1 and RIPK3 in a dose-dependent manner.